David F. Carmichael

Person

Monrovia, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Optimized anti-CD30 antibodies
- Patent number 9,574,006
- Issue date Feb 21, 2017
- Xencor, Inc.
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified FC molecules
- Patent number 9,040,041
- Issue date May 26, 2015
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Optimized anti-CD30 antibodies
- Patent number 7,973,136
- Issue date Jul 5, 2011
- Xencor, Inc.
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical compositions for the treatment of TNF-α related diso...
- Patent number 7,662,367
- Issue date Feb 16, 2010
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Optimized Anti-CD30 Antibodies
- Publication number 20120014943
- Publication date Jan 19, 2012
- Xencor, Inc.
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED Fc MOLECULES
- Publication number 20100249382
- Publication date Sep 30, 2010
- Xencor, Inc.
- JOHN R. DESJARLAIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pharmaceutical Compositions for the Treatment of TNF-Alpha Related...
- Publication number 20100222272
- Publication date Sep 2, 2010
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Optimized Anti-Cd30 Antibodies
- Publication number 20080267976
- Publication date Oct 30, 2008
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fc variants with optimized Fc receptor binding properties
- Publication number 20080206867
- Publication date Aug 28, 2008
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pharmaceutical compositions for the treatment of TNF-alpha related...
- Publication number 20080187509
- Publication date Aug 7, 2008
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc Variants With Optimized Fc Receptor Binding Properties
- Publication number 20070275460
- Publication date Nov 29, 2007
- Xencor.Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELAT...
- Publication number 20070172449
- Publication date Jul 26, 2007
- Xencor, Inc.
- David F. Carmichael
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTI-CD30 ANTIBODIES
- Publication number 20070166309
- Publication date Jul 19, 2007
- Xencor, Inc.
- Gregory Alan Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Optimized anti-CD30 antibodies
- Publication number 20070148171
- Publication date Jun 28, 2007
- Xencor, Inc.
- Gregory Alan Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc Variants With Optimized Fc Receptor Binding Properties
- Publication number 20070148170
- Publication date Jun 28, 2007
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY

David F. Carmichael

Person

Patents Grantslast 30 patents

Optimized anti-CD30 antibodies

Modified FC molecules

Optimized anti-CD30 antibodies

Pharmaceutical compositions for the treatment of TNF-α related diso...

Patents Applicationslast 30 patents

Optimized Anti-CD30 Antibodies

MODIFIED Fc MOLECULES

Pharmaceutical Compositions for the Treatment of TNF-Alpha Related...

Optimized Anti-Cd30 Antibodies

Fc variants with optimized Fc receptor binding properties

Pharmaceutical compositions for the treatment of TNF-alpha related...

Fc Variants With Optimized Fc Receptor Binding Properties

TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELAT...

OPTIMIZED ANTI-CD30 ANTIBODIES

Optimized anti-CD30 antibodies

Fc Variants With Optimized Fc Receptor Binding Properties